I agree that this site is using cookies. You can find further informations here.
X
Santin, Alessandro D.
481  results:
Search for persons X
?
1

Preclinical activity of datopotamab deruxtecan, a novel TRO..:

McNamara, Blair ; Greenman, Michelle ; Bellone, Stefania...
Gynecologic Oncology.  189 (2024)  - p. 16-23 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Microtubule-Targeting Agents: Disruption of the Cellular Cy..:

, In: Advances in Experimental Medicine and Biology; Cell and Molecular Biology of Ovarian Cancer,
Danziger, Michael ; Noble, Helen ; Roque, Dana M.... - p. 1-19 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Entering the golden age for antibody-drug conjugates in gyn..:

Greenman, Michelle ; McNamara, Blair ; Mutlu, Levent.
Oncoscience.  11 (2024)  - p. 51-52 , 2024
Link: https://doi.org/10.18632..
 
?
4

Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibod..:

Mutlu, Levent ; McNamara, Blair ; Bellone, Stefania...
Clinical & Experimental Metastasis.  , 2024
Link: https://doi.org/10.1007/..
 
?
5

Preclinical efficacy of RAF/MEK clamp avutometinib in combi..:

McNamara, Blair ; Demirkiran, Cem ; Hartwich, Tobias Max Philipp...
Gynecologic Oncology.  183 (2024)  - p. 133-140 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Sacituzumab govitecan in heavily pretreated, platinum-resis..:

Greenman, Michelle ; Bellone, Stefania ; Demirkiran, Cem..
Gynecologic Oncology Reports.  54 (2024)  - p. 101459 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Preclinical in vitro and in vivo activity of the RAF/MEK cl..:

Demirkiran, Cem ; Greenman, Michelle ; Bellone, Stefania...
Gynecologic Oncology.  187 (2024)  - p. 12-20 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Randomized phase II trial of weekly ixabepilone ± biweekly ..:

Roque, Dana M. ; Siegel, Eric R. ; Buza, Natalia...
BJC Reports.  2 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
9

Increased von Willebrand and Factor VIII plasma levels in g..:

Bellone, Stefania ; Siegel, Eric R. ; Scheim, David E..
Gynecologic Oncology Reports.  51 (2024)  - p. 101324 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Correction: Randomised phase II trial of weekly ixabepilone..:

Roque, Dana M. ; Siegel, Eric R. ; Buza, Natalia...
British Journal of Cancer.  130 (2024)  6 - p. 1073-1073 , 2024
Link: https://doi.org/10.1038/..
 
?
11

The Poly (ADP-ribose) polymerase inhibitor olaparib and pan..:

Han, Chanhee ; McNamara, Blair ; Bellone, Stefania...
Gynecologic Oncology.  170 (2023)  - p. 172-178 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to..:

Scheim, David E. ; Vottero, Paola ; Santin, Alessandro D..
International Journal of Molecular Sciences.  24 (2023)  23 - p. 17039 , 2023
Link: https://doi.org/10.3390/..
 
?
13

Molecular determinants of clinical outcomes of pembrolizuma..:

Ledermann, Jonathan A. ; Shapira-Frommer, Ronnie ; Santin, Alessandro D....
Gynecologic Oncology.  178 (2023)  - p. 119-129 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrat..:

Harold, Justin ; Bellone, Stefania ; Manavella, Diego D....
Gynecologic Oncology.  168 (2023)  - p. 157-165 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Computational Prediction of the Interaction of Ivermectin w..:

Vottero, Paola ; Tavernini, Scott ; Santin, Alessandro D....
International Journal of Molecular Sciences.  24 (2023)  14 - p. 11449 , 2023
Link: https://doi.org/10.3390/..
 
1-15